Vaccine

Germans are increasingly losing faith in the European Union due to its bungled handling of the vaccine roll-out. Germany and the other member states have assigned Brussels to organise and oversee the procurement and distribution of Covid jabs. But, so far, the roll-out has been a logistic mess. According to a poll by Civey, commissioned by the German newspaper Der Spiegel, more than 60 per cent of German citizens said their view of Brussels had worsened in light of the disastrous vaccination management. Almost 70 per cent laid the blame at the feet of fellow German Ursula von der Leyen, the President of the European Commission, who admitted last week that ‘mistakes were made’ in the bloc’s approach to the procurement of jabs.

It is a rant worthy of Nigel Farage in his pomp. One of the leading figures within the European Parliament has launched a blistering tirade against the Commission's ineptitude in securing vaccines. The EU is a world leader in making inoculations, he points out. And yet there is a shortage of supply in every country within the Union. The measures taken to fix that so far have been ‘symbolic,’ ‘insufficient’ and sometimes even ‘counterproductive’. Worse, there has been a shocking lack of accountability, with no one held responsible for the failure. The critic? None other than the arch federalist, scourge of Brexiteers, and hero of Lib Dem party conferences, Guy Verhofstadt.

France has become the first country in the world to recommend a different vaccine regime for those who have recovered from the virus. The country’s public health authority has recommended that people previously infected with Covid-19 only receive one jab, rather than two. The advice is based on preliminary data, including two studies from the United States, that show the combination of antibodies built up from having the virus, plus one jab, creates immunity that ‘is equal to or even exceeds’ having two vaccines. It wasn’t long ago that French ministers were publicly criticising the UK’s strategy It’s too early to definitively say whether France’s strategy will work. For one thing, the government hasn't signed it off yet.

You have to admire Hungary’s chutzpah. Not only has it bypassed Brussels to pursue its own vaccine procurement strategy, it is also backing two of the most controversial horses in the race: Russia’s Sputnik V and China’s Sinopharm jab. It has just secured enough Sinopharm doses to vaccinate 250,000 people a month while its Sputnik V deal will mean 1 million Hungarians are vaccinated – a tenth of the population. The Sputnik V vaccine may start being rolled out as soon as next week. Hungary’s strategy may appear reckless but its hand has been somewhat forced by EU policy, which prohibitively states that individual member states may only enter into negotiations with vaccine suppliers who are not in talks with the EU.